- Home
- PRPL vs ANIX Comparison
PRPL vs ANIX Comparison
Compare PRPL & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- ANIX
- Stock Information
- Founded
- PRPL 2010
- ANIX 1982
- Country
- PRPL United States
- ANIX United States
- Employees
- PRPL N/A
- ANIX N/A
- Industry
- PRPL Home Furnishings
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- PRPL Consumer Discretionary
- ANIX Health Care
- Exchange
- PRPL Nasdaq
- ANIX Nasdaq
- Market Cap
- PRPL 90.3M
- ANIX 84.7M
- IPO Year
- PRPL N/A
- ANIX 1987
- Fundamental
- Price
- PRPL $0.66
- ANIX $2.81
- Analyst Decision
- PRPL Buy
- ANIX Strong Buy
- Analyst Count
- PRPL 3
- ANIX 2
- Target Price
- PRPL $1.70
- ANIX $8.50
- AVG Volume (30 Days)
- PRPL 403.9K
- ANIX 93.0K
- Earning Date
- PRPL 03-13-2025
- ANIX 03-11-2025
- Dividend Yield
- PRPL N/A
- ANIX N/A
- EPS Growth
- PRPL N/A
- ANIX N/A
- EPS
- PRPL N/A
- ANIX N/A
- Revenue
- PRPL $504,838,000.00
- ANIX N/A
- Revenue This Year
- PRPL N/A
- ANIX N/A
- Revenue Next Year
- PRPL $1.83
- ANIX N/A
- P/E Ratio
- PRPL N/A
- ANIX N/A
- Revenue Growth
- PRPL N/A
- ANIX N/A
- 52 Week Low
- PRPL $0.65
- ANIX $2.07
- 52 Week High
- PRPL $2.12
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- PRPL 23.09
- ANIX 47.21
- Support Level
- PRPL $0.77
- ANIX $2.58
- Resistance Level
- PRPL $0.85
- ANIX $2.97
- Average True Range (ATR)
- PRPL 0.06
- ANIX 0.20
- MACD
- PRPL -0.02
- ANIX -0.04
- Stochastic Oscillator
- PRPL 4.60
- ANIX 40.35
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.